What Should a Retatrutide COA Include

A certificate of analysis, or COA, is the document a lab issues after testing a specific batch of material. When asking what should a retatrutide COA include, the short answer is four things: confirmation the peptide is actually retatrutide, a purity figure from a chromatography method, a mass or peptide-content value, and batch-identifying details that tie the document to the exact vial in hand. A COA that is missing any of these is incomplete, and a COA that cannot be matched to a specific batch number is not useful for verification purposes.

Identity Testing

Identity testing answers a narrower question than purity: is the molecule in the vial actually retatrutide, and not a different peptide entirely, an analog, or a mixture. Labs commonly use mass spectrometry for this, which measures the molecular weight of the sample and compares it against the expected mass of retatrutide. Some COAs also report amino acid analysis, which confirms the sequence rather than just the mass. A COA that lists only a purity percentage without any identity confirmation leaves open the possibility that a high-purity reading was generated on the wrong molecule.

Purity by HPLC

Purity is usually reported as a percentage generated by high-performance liquid chromatography, abbreviated HPLC. The method separates the components of a sample by how they interact with a column, then measures the area under each resulting peak. The retatrutide peak’s area as a percentage of the total peak area is the purity figure quoted on the COA. A complete COA states the method (HPLC, and ideally the specific variant such as RP-HPLC), the purity percentage, and sometimes the retention time of the main peak, which lets a chemist cross-check the run against reference data.

A purity percentage without a stated method is a weaker data point than one with the method disclosed, since different HPLC conditions can produce different apparent purity values for the same sample.

Mass Balance and Peptide Content

Purity by HPLC only measures the relative proportion of retatrutide among the peaks the method detects. It does not confirm how much actual peptide mass is present versus water, salts, or counter-ions left over from synthesis. That second figure is called peptide content or mass balance, and it is typically generated by a separate assay such as amino acid analysis or a gravimetric comparison. A vial can show 99% HPLC purity while containing meaningfully less than the labeled milligram amount of actual peptide, because the purity percentage describes the ratio between peaks, not the total mass recovered. A COA that reports both the HPLC purity and a peptide content or net peptide value gives a fuller picture than one that reports purity alone.

Batch and Traceability Details

A COA is only as useful as its connection to the specific vial being checked. Traceability fields that a complete document should include:

Field	What it confirms
Batch or lot number	Ties the COA to a specific production run, not the compound generally
Manufacture or test date	Indicates how recently the analysis was performed
Testing lab name	Identifies who ran the assays, allowing independent verification
Method reference	States which chromatography or mass spec protocol was used
Molecular weight found	The measured mass, for comparison against the theoretical value

Without a batch number, a COA cannot be distinguished from a generic reference document that may not correspond to the vial it accompanies. Sellers who reuse a single COA across multiple batches are not providing batch-specific verification, regardless of how detailed the document otherwise looks.

Sterility and Endotoxin Data

Some COAs include sterility and endotoxin testing, which are separate from identity and purity. Sterility testing checks for microbial contamination, and endotoxin testing measures bacterial endotoxin levels, usually reported in EU/mg (endotoxin units per milligram). These tests are more commonly seen on COAs for lyophilized peptides intended for reconstitution and are not universal across every listing. When present, they add a layer of documentation beyond chemical identity, describing the biological cleanliness of the sample rather than its molecular composition.

Reading a COA Alongside a Listing

A listing description and a COA describe two different things: the listing describes what the seller states about the product, and the COA describes what a lab measured on a specific batch. Cross-referencing the two is a matter of checking that the batch number on the COA matches the batch identifier on the vial or listing, and that the compound name and molecular weight line up with what is expected for retatrutide. Independent reference material, such as the retatrutide overview maintained by HEEZ Research, can help confirm the expected molecular weight and general specification range before comparing it against a specific COA. General background on peptide naming and classification is also covered on glp3rt.net, which is useful context for readers comparing terminology across different compound families.

Common Gaps in Incomplete COAs

Several patterns show up in COAs that fall short of what should a retatrutide COA include:

• Purity stated with no method disclosed
• No batch or lot number, making the document impossible to tie to a specific vial
• No molecular weight or identity confirmation, only a purity percentage
• A test date far removed from the batch’s actual production, suggesting the document may not correspond to current stock
• No named testing lab, making independent verification impossible

Any one of these gaps reduces how much a COA can be relied on for verification, and multiple gaps together generally indicate a document that functions more as a marketing artifact than a genuine analytical record. Readers comparing sourcing options across suppliers can find further catalogue-level detail at retatrutideonline.net.

Summary

A complete retatrutide COA identifies the molecule through mass spectrometry or a comparable method, reports purity via HPLC with the method disclosed, states a peptide content or mass balance figure separate from the purity percentage, and includes a batch number, test date, and testing lab that tie the document to a specific vial. Sterility and endotoxin data may appear as well, depending on the product. Documents missing identity confirmation, batch traceability, or method disclosure fall short of what a genuinely verifiable COA should contain, regardless of how polished the purity number looks on its own.